paclitaxel Search Results


taxol  (Cytoskeleton Inc)
95
Cytoskeleton Inc taxol
Taxol, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/taxol/product/Cytoskeleton Inc
Average 95 stars, based on 1 article reviews
taxol - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier
paclitaxel  (Thermo Fisher)
95
Thermo Fisher paclitaxel
Paclitaxel, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/paclitaxel/product/Thermo Fisher
Average 95 stars, based on 1 article reviews
paclitaxel - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier
cephalomannine ceph  (ChromaDex)
91
ChromaDex cephalomannine ceph
Cephalomannine Ceph, supplied by ChromaDex, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cephalomannine ceph/product/ChromaDex
Average 91 stars, based on 1 article reviews
cephalomannine ceph - by Bioz Stars, 2026-02
91/100 stars
  Buy from Supplier
paclitaxel  (Cell Signaling Technology Inc)
95
Cell Signaling Technology Inc paclitaxel
Figure 6. Reduction of RUNX1 transcriptional activity enhances enzalutamide and <t>paclitaxel</t> treat- ment in CSC-like cells. MDA-MB-453 cells were cultured for 72 h in forced-suspension and treated with either 10 nM Px, 40 µM Enza and 2 µM AI-10-104 (A)/0.5 µM AI-10-49 (B) or the doses used for attached conditions (dark gray bar): 2 nM Px, 20 µM Enza and 1 µM AI-10-104 (A)/0.25 µM AI-10-49 (B) for 72 h. Cell viability was determined by MTT and the results are expressed as the relative absorbance (570 nm) to control treatment (DMSO, 1.00). Statistical differences are shown for the combination of the 3 drugs (black bar) vs. the rest of the treatments (gray bars) or vehicle (white bar). For more details see Suppl Table S3. One-way ANOVA with Tukey multiple comparison was performed from three independent experiments, * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.
Paclitaxel, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/paclitaxel/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
paclitaxel - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier
microtubules  (Cytoskeleton Inc)
95
Cytoskeleton Inc microtubules
Figure 6. Reduction of RUNX1 transcriptional activity enhances enzalutamide and <t>paclitaxel</t> treat- ment in CSC-like cells. MDA-MB-453 cells were cultured for 72 h in forced-suspension and treated with either 10 nM Px, 40 µM Enza and 2 µM AI-10-104 (A)/0.5 µM AI-10-49 (B) or the doses used for attached conditions (dark gray bar): 2 nM Px, 20 µM Enza and 1 µM AI-10-104 (A)/0.25 µM AI-10-49 (B) for 72 h. Cell viability was determined by MTT and the results are expressed as the relative absorbance (570 nm) to control treatment (DMSO, 1.00). Statistical differences are shown for the combination of the 3 drugs (black bar) vs. the rest of the treatments (gray bars) or vehicle (white bar). For more details see Suppl Table S3. One-way ANOVA with Tukey multiple comparison was performed from three independent experiments, * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.
Microtubules, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microtubules/product/Cytoskeleton Inc
Average 95 stars, based on 1 article reviews
microtubules - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier
paclitaxel  (MedChemExpress)
96
MedChemExpress paclitaxel
Figure 6. Reduction of RUNX1 transcriptional activity enhances enzalutamide and <t>paclitaxel</t> treat- ment in CSC-like cells. MDA-MB-453 cells were cultured for 72 h in forced-suspension and treated with either 10 nM Px, 40 µM Enza and 2 µM AI-10-104 (A)/0.5 µM AI-10-49 (B) or the doses used for attached conditions (dark gray bar): 2 nM Px, 20 µM Enza and 1 µM AI-10-104 (A)/0.25 µM AI-10-49 (B) for 72 h. Cell viability was determined by MTT and the results are expressed as the relative absorbance (570 nm) to control treatment (DMSO, 1.00). Statistical differences are shown for the combination of the 3 drugs (black bar) vs. the rest of the treatments (gray bars) or vehicle (white bar). For more details see Suppl Table S3. One-way ANOVA with Tukey multiple comparison was performed from three independent experiments, * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.
Paclitaxel, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/paclitaxel/product/MedChemExpress
Average 96 stars, based on 1 article reviews
paclitaxel - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier
taxol  (MedChemExpress)
93
MedChemExpress taxol
Figure 6. Reduction of RUNX1 transcriptional activity enhances enzalutamide and <t>paclitaxel</t> treat- ment in CSC-like cells. MDA-MB-453 cells were cultured for 72 h in forced-suspension and treated with either 10 nM Px, 40 µM Enza and 2 µM AI-10-104 (A)/0.5 µM AI-10-49 (B) or the doses used for attached conditions (dark gray bar): 2 nM Px, 20 µM Enza and 1 µM AI-10-104 (A)/0.25 µM AI-10-49 (B) for 72 h. Cell viability was determined by MTT and the results are expressed as the relative absorbance (570 nm) to control treatment (DMSO, 1.00). Statistical differences are shown for the combination of the 3 drugs (black bar) vs. the rest of the treatments (gray bars) or vehicle (white bar). For more details see Suppl Table S3. One-way ANOVA with Tukey multiple comparison was performed from three independent experiments, * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.
Taxol, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/taxol/product/MedChemExpress
Average 93 stars, based on 1 article reviews
taxol - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier
paclitaxel  (Cytoskeleton Inc)
97
Cytoskeleton Inc paclitaxel
The summary table of several significant anti-tumor TCMs.
Paclitaxel, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/paclitaxel/product/Cytoskeleton Inc
Average 97 stars, based on 1 article reviews
paclitaxel - by Bioz Stars, 2026-02
97/100 stars
  Buy from Supplier
doxorubicin  (Selleck Chemicals)
96
Selleck Chemicals doxorubicin
The summary table of several significant anti-tumor TCMs.
Doxorubicin, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/doxorubicin/product/Selleck Chemicals
Average 96 stars, based on 1 article reviews
doxorubicin - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier
wt wt paclitaxel  (Valiant Co Ltd)
93
Valiant Co Ltd wt wt paclitaxel
The summary table of several significant anti-tumor TCMs.
Wt Wt Paclitaxel, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wt wt paclitaxel/product/Valiant Co Ltd
Average 93 stars, based on 1 article reviews
wt wt paclitaxel - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier
taxol  (Santa Cruz Biotechnology)
93
Santa Cruz Biotechnology taxol
The summary table of several significant anti-tumor TCMs.
Taxol, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/taxol/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
taxol - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier
deuterium labeled paclitaxel paclitaxel d5  (Santa Cruz Biotechnology)
91
Santa Cruz Biotechnology deuterium labeled paclitaxel paclitaxel d5
The summary table of several significant anti-tumor TCMs.
Deuterium Labeled Paclitaxel Paclitaxel D5, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/deuterium labeled paclitaxel paclitaxel d5/product/Santa Cruz Biotechnology
Average 91 stars, based on 1 article reviews
deuterium labeled paclitaxel paclitaxel d5 - by Bioz Stars, 2026-02
91/100 stars
  Buy from Supplier

Image Search Results


Figure 6. Reduction of RUNX1 transcriptional activity enhances enzalutamide and paclitaxel treat- ment in CSC-like cells. MDA-MB-453 cells were cultured for 72 h in forced-suspension and treated with either 10 nM Px, 40 µM Enza and 2 µM AI-10-104 (A)/0.5 µM AI-10-49 (B) or the doses used for attached conditions (dark gray bar): 2 nM Px, 20 µM Enza and 1 µM AI-10-104 (A)/0.25 µM AI-10-49 (B) for 72 h. Cell viability was determined by MTT and the results are expressed as the relative absorbance (570 nm) to control treatment (DMSO, 1.00). Statistical differences are shown for the combination of the 3 drugs (black bar) vs. the rest of the treatments (gray bars) or vehicle (white bar). For more details see Suppl Table S3. One-way ANOVA with Tukey multiple comparison was performed from three independent experiments, * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.

Journal: Cells

Article Title: RUNX1 Is Regulated by Androgen Receptor to Promote Cancer Stem Markers and Chemotherapy Resistance in Triple Negative Breast Cancer.

doi: 10.3390/cells12030444

Figure Lengend Snippet: Figure 6. Reduction of RUNX1 transcriptional activity enhances enzalutamide and paclitaxel treat- ment in CSC-like cells. MDA-MB-453 cells were cultured for 72 h in forced-suspension and treated with either 10 nM Px, 40 µM Enza and 2 µM AI-10-104 (A)/0.5 µM AI-10-49 (B) or the doses used for attached conditions (dark gray bar): 2 nM Px, 20 µM Enza and 1 µM AI-10-104 (A)/0.25 µM AI-10-49 (B) for 72 h. Cell viability was determined by MTT and the results are expressed as the relative absorbance (570 nm) to control treatment (DMSO, 1.00). Statistical differences are shown for the combination of the 3 drugs (black bar) vs. the rest of the treatments (gray bars) or vehicle (white bar). For more details see Suppl Table S3. One-way ANOVA with Tukey multiple comparison was performed from three independent experiments, * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.

Article Snippet: Dihydrotestosterone (DHT, Sigma-Aldrich) was diluted in ethanol, enzalutamide (Enza, Sigma-Aldrich; #PHB00235) in DMSO, Paclitaxel (Px, Cell Signaling Technology, Danvers, MA, USA; #98075) in DMSO and RUNX1 inhibitors AI-10-104 (Glixx Laboratories, Hopkinton, MA, USA; GLXC-20705) and AI-10-49 (Glixx Laboratories GLXC-07203) in DMSO.

Techniques: Activity Assay, Cell Culture, Suspension, Control, Comparison

The summary table of several significant anti-tumor TCMs.

Journal: Frontiers in Immunology

Article Title: Harnessing the power of traditional Chinese medicine monomers and compound prescriptions to boost cancer immunotherapy

doi: 10.3389/fimmu.2023.1277243

Figure Lengend Snippet: The summary table of several significant anti-tumor TCMs.

Article Snippet: , Paclitaxel (PubChem CID: 36314) , , Stabilizing microtubules, inducing cell cycle arrest and inhibition of cell division , Microtubule protein; tubulin , 1)antibody-drug conjugate: ADC cytotoxin; 2)cytoskeleton: microtubules/tubulin; 3)mitotic checkpoint pathway; 4)apoptotic pathways , ( , ) .

Techniques: Inhibition, Activity Assay

Closed and ongoing national clinical trials (NCT) on the association between TCMs and multiple cancer types.

Journal: Frontiers in Immunology

Article Title: Harnessing the power of traditional Chinese medicine monomers and compound prescriptions to boost cancer immunotherapy

doi: 10.3389/fimmu.2023.1277243

Figure Lengend Snippet: Closed and ongoing national clinical trials (NCT) on the association between TCMs and multiple cancer types.

Article Snippet: , Paclitaxel (PubChem CID: 36314) , , Stabilizing microtubules, inducing cell cycle arrest and inhibition of cell division , Microtubule protein; tubulin , 1)antibody-drug conjugate: ADC cytotoxin; 2)cytoskeleton: microtubules/tubulin; 3)mitotic checkpoint pathway; 4)apoptotic pathways , ( , ) .

Techniques: Adjuvant, Mutagenesis, Expressing, Injection, Activation Assay, In Vivo